Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Learning Curve for Robot-Assisted Percutaneous Pedicle Screw Placement in Thoracolumbar Surgery.

Kam JKT, Gan C, Dimou S, Awad M, Kavar B, Nair G, Morokoff A.

Asian Spine J. 2019 Jul 9. doi: 10.31616/asj.2019.0033. [Epub ahead of print]

2.

Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.

Luwor R, Morokoff AP, Amiridis S, D'Abaco G, Paradiso L, Stylli SS, Nguyen HPT, Tarleton M, Young KA, O'Brien TJ, Robinson PJ, Chircop M, McCluskey A, Jones NC.

Cancer Invest. 2019;37(3):144-155. doi: 10.1080/07357907.2019.1582060. Epub 2019 Mar 25.

PMID:
30907150
3.

Glutamate weighted imaging contrast in gliomas with 7 Tesla magnetic resonance imaging.

Neal A, Moffat BA, Stein JM, Nanga RPR, Desmond P, Shinohara RT, Hariharan H, Glarin R, Drummond K, Morokoff A, Kwan P, Reddy R, O'Brien TJ, Davis KA.

Neuroimage Clin. 2019;22:101694. doi: 10.1016/j.nicl.2019.101694. Epub 2019 Jan 29.

4.

Metabolic patterns and seizure outcomes following anterior temporal lobectomy.

Cahill V, Sinclair B, Malpas CB, McIntosh AM, Chen Z, Vivash LE, O'Shea MF, Wilson SJ, Desmond PM, Berlangieri SU, Hicks RJ, Rowe CC, Morokoff AP, King JA, Fabinyi GC, Kaye AH, Kwan P, Berkovic SF, O'Brien TJ.

Ann Neurol. 2019 Feb;85(2):241-250. doi: 10.1002/ana.25405. Epub 2019 Jan 17.

PMID:
30609109
5.

Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.

Atkins RJ, Stylli SS, Kurganovs N, Mangiola S, Nowell CJ, Ware TM, Corcoran NM, Brown DV, Kaye AH, Morokoff A, Luwor RB, Hovens CM, Mantamadiotis T.

Exp Cell Res. 2019 Jan 15;374(2):353-364. doi: 10.1016/j.yexcr.2018.12.010. Epub 2018 Dec 15.

PMID:
30562483
6.

VDAC2 enables BAX to mediate apoptosis and limit tumor development.

Chin HS, Li MX, Tan IKL, Ninnis RL, Reljic B, Scicluna K, Dagley LF, Sandow JJ, Kelly GL, Samson AL, Chappaz S, Khaw SL, Chang C, Morokoff A, Brinkmann K, Webb A, Hockings C, Hall CM, Kueh AJ, Ryan MT, Kluck RM, Bouillet P, Herold MJ, Gray DHD, Huang DCS, van Delft MF, Dewson G.

Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.

7.

The role of interleukin-6-STAT3 signalling in glioblastoma.

West AJ, Tsui V, Stylli SS, Nguyen HPT, Morokoff AP, Kaye AH, Luwor RB.

Oncol Lett. 2018 Oct;16(4):4095-4104. doi: 10.3892/ol.2018.9227. Epub 2018 Jul 27. Review.

8.

Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.

Whitehead CA, Nguyen HPT, Morokoff AP, Luwor RB, Paradiso L, Kaye AH, Mantamadiotis T, Stylli SS.

Transl Oncol. 2018 Dec;11(6):1406-1418. doi: 10.1016/j.tranon.2018.08.012. Epub 2018 Sep 13.

9.

The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol.

Vespa PM, Shrestha V, Abend N, Agoston D, Au A, Bell MJ, Bleck TP, Blanco MB, Claassen J, Diaz-Arrastia R, Duncan D, Ellingson B, Foreman B, Gilmore EJ, Hirsch L, Hunn M, Kamnaksh A, McArthur D, Morokoff A, O'Brien T, O'Phelan K, Robertson CL, Rosenthal E, Staba R, Toga A, Willyerd FA, Zimmermann L, Yam E, Martinez S, Real C, Engel J Jr.

Neurobiol Dis. 2019 Mar;123:110-114. doi: 10.1016/j.nbd.2018.07.025. Epub 2018 Jul 23. Review.

PMID:
30048805
10.

A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.

Ma C, Nguyen HPT, Luwor RB, Stylli SS, Gogos A, Paradiso L, Kaye AH, Morokoff AP.

PLoS One. 2018 Feb 14;13(2):e0189452. doi: 10.1371/journal.pone.0189452. eCollection 2018.

11.

IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.

Neal A, Kwan P, O'Brien TJ, Buckland ME, Gonzales M, Morokoff A.

Epilepsy Behav. 2018 Jan;78:30-36. doi: 10.1016/j.yebeh.2017.10.027. Epub 2017 Dec 22.

PMID:
29172136
12.

Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.

Mao L, Whitehead CA, Paradiso L, Kaye AH, Morokoff AP, Luwor RB, Stylli SS.

J Neurosurg. 2018 Sep;129(3):598-610. doi: 10.3171/2017.5.JNS17845. Epub 2017 Nov 17.

PMID:
29148898
13.

First line direct access for transarterial embolization of a dural arteriovenous fistula: Case report and literature review.

Doolan BJ, Paldor I, Mitchell PJ, Morokoff AP.

J Clin Neurosci. 2018 Feb;48:214-217. doi: 10.1016/j.jocn.2017.10.070. Epub 2017 Nov 11. Review.

PMID:
29137915
14.

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.

Brown DV, Filiz G, Daniel PM, Hollande F, Dworkin S, Amiridis S, Kountouri N, Ng W, Morokoff AP, Mantamadiotis T.

PLoS One. 2017 Feb 27;12(2):e0172791. doi: 10.1371/journal.pone.0172791. eCollection 2017.

15.

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.

Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP.

J Neurooncol. 2017 Jan;131(2):321-329. doi: 10.1007/s11060-016-2300-0. Epub 2016 Nov 28.

PMID:
27896520
16.

The emergent role of exosomes in glioma.

Gourlay J, Morokoff AP, Luwor RB, Zhu HJ, Kaye AH, Stylli SS.

J Clin Neurosci. 2017 Jan;35:13-23. doi: 10.1016/j.jocn.2016.09.021. Epub 2016 Oct 19. Review.

PMID:
27771233
17.

Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.

Tully PA, Gogos AJ, Love C, Liew D, Drummond KJ, Morokoff AP.

Neurosurgery. 2016 Nov;79(5):678-689.

PMID:
27409404
18.

Postoperative seizure control in patients with tumor-associated epilepsy.

Neal A, Morokoff A, O'Brien TJ, Kwan P.

Epilepsia. 2016 Nov;57(11):1779-1788. doi: 10.1111/epi.13562. Epub 2016 Sep 26.

19.

Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas.

Neal A, Yuen T, Bjorksten AR, Kwan P, O'Brien TJ, Morokoff A.

J Neurooncol. 2016 Sep;129(2):259-67. doi: 10.1007/s11060-016-2169-y. Epub 2016 Jun 16.

PMID:
27311724
20.

Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.

Areeb Z, Stylli SS, Ware TM, Harris NC, Shukla L, Shayan R, Paradiso L, Li B, Morokoff AP, Kaye AH, Luwor RB.

Med Oncol. 2016 May;33(5):53. doi: 10.1007/s12032-016-0767-3. Epub 2016 Apr 20.

PMID:
27098175
21.

Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab.

Siegal T, Charbit H, Paldor I, Zelikovitch B, Canello T, Benis A, Wong ML, Morokoff AP, Kaye AH, Lavon I.

J Neurosurg. 2016 Oct;125(4):1008-1015. Epub 2016 Jan 22.

PMID:
26799295
22.

MicroRNA as potential biomarkers in Glioblastoma.

Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, Morokoff AP, Kaye AH, Luwor RB.

J Neurooncol. 2015 Nov;125(2):237-48. doi: 10.1007/s11060-015-1912-0. Epub 2015 Sep 21. Review.

PMID:
26391593
23.

Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.

Bennett IE, Guo H, Kountouri N, D'abaco GM, Hovens CM, Moffat BA, Desmond P, Drummond K, Kaye AH, Morokoff AP.

J Clin Neurosci. 2015 Nov;22(11):1802-8. doi: 10.1016/j.jocn.2015.06.013. Epub 2015 Aug 22.

PMID:
26308396
24.

Large suprasellar mass: question.

Sim K, Morokoff A, Tsui A, Gaillard F.

J Clin Neurosci. 2015 Jul;22(7):1183, 1218. No abstract available.

PMID:
26236828
25.

The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.

Ching J, Amiridis S, Stylli SS, Bjorksten AR, Kountouri N, Zheng T, Paradiso L, Luwor RB, Morokoff AP, O'Brien TJ, Kaye AH.

Oncotarget. 2015 Aug 28;6(25):21301-14.

26.

Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.

Morokoff A, Ng W, Gogos A, Kaye AH.

J Clin Neurosci. 2015 Aug;22(8):1219-26. doi: 10.1016/j.jocn.2015.02.008. Epub 2015 May 6. Review.

PMID:
25957782
27.

Occult temporal lobe encephalocoele into the transverse sinus.

Asadi H, Morokoff A, Gaillard F.

J Clin Neurosci. 2015 Jul;22(7):1202-4. doi: 10.1016/j.jocn.2015.01.020. Epub 2015 Apr 15.

PMID:
25890775
28.

Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.

Brown DV, Daniel PM, D'Abaco GM, Gogos A, Ng W, Morokoff AP, Mantamadiotis T.

Oncotarget. 2015 Mar 20;6(8):6267-80.

29.

A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPARγ agonists.

Ching J, Amiridis S, Stylli SS, Morokoff AP, O'Brien TJ, Kaye AH.

J Clin Neurosci. 2015 Jan;22(1):21-8. doi: 10.1016/j.jocn.2014.09.001. Epub 2014 Nov 22. Review.

PMID:
25439749
30.

In response: IDH1 mutation expression is associated with seizures and protoplasmic subtype in patients with low-grade glioma.

Morokoff A, Liubinas S.

Epilepsia. 2014 Oct;55(10):1679-80. doi: 10.1111/epi.12759. No abstract available.

31.

The continuing evolution: biology and treatment of brain tumors.

Kaye AH, Morokoff A.

Neurosurgery. 2014 Aug;61 Suppl 1:100-4. doi: 10.1227/NEU.0000000000000388. Review. No abstract available.

PMID:
25032537
32.

IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.

Liubinas SV, D'Abaco GM, Moffat BM, Gonzales M, Feleppa F, Nowell CJ, Gorelik A, Drummond KJ, O'Brien TJ, Kaye AH, Morokoff AP.

Epilepsia. 2014 Sep;55(9):1438-43. doi: 10.1111/epi.12662. Epub 2014 Jun 5.

33.

Tumour associated epilepsy and glutamate excitotoxicity in patients with gliomas.

Liubinas SV, O'Brien TJ, Moffat BM, Drummond KJ, Morokoff AP, Kaye AH.

J Clin Neurosci. 2014 Jun;21(6):899-908. doi: 10.1016/j.jocn.2014.02.012. Epub 2014 Apr 17. Review.

PMID:
24746886
34.

Complexities of lysophospholipid signalling in glioblastoma.

Ng W, Pébay A, Drummond K, Burgess A, Kaye AH, Morokoff A.

J Clin Neurosci. 2014 Jun;21(6):893-8. doi: 10.1016/j.jocn.2014.02.013. Epub 2014 Apr 18. Review.

PMID:
24746442
35.

Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging.

Liubinas SV, Drummond KJ, Desmond PM, Bjorksten A, Morokoff AP, Kaye AH, O'Brien TJ, Moffat BA.

NMR Biomed. 2014 May;27(5):570-7. doi: 10.1002/nbm.3095. Epub 2014 Mar 25.

PMID:
24664947
36.

Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study.

Cook MJ, O'Brien TJ, Berkovic SF, Murphy M, Morokoff A, Fabinyi G, D'Souza W, Yerra R, Archer J, Litewka L, Hosking S, Lightfoot P, Ruedebusch V, Sheffield WD, Snyder D, Leyde K, Himes D.

Lancet Neurol. 2013 Jun;12(6):563-71. doi: 10.1016/S1474-4422(13)70075-9. Epub 2013 May 2.

PMID:
23642342
37.

Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.

Atkins RJ, Dimou J, Paradiso L, Morokoff AP, Kaye AH, Drummond KJ, Hovens CM.

J Clin Neurosci. 2012 Nov;19(11):1558-63. doi: 10.1016/j.jocn.2012.07.002. Epub 2012 Sep 19.

PMID:
22999562
38.

Glutamate is associated with a higher risk of seizures in patients with gliomas.

Yuen TI, Morokoff AP, Bjorksten A, D'Abaco G, Paradiso L, Finch S, Wong D, Reid CA, Powell KL, Drummond KJ, Rosenthal MA, Kaye AH, O'Brien TJ.

Neurology. 2012 Aug 28;79(9):883-9. doi: 10.1212/WNL.0b013e318266fa89. Epub 2012 Jul 25.

PMID:
22843268
39.

An unusual cause of skull and cervical spine masses. Multiple myeloma.

Liubinas SV, Morokoff AP.

J Clin Neurosci. 2011 Jul;18(7):945, 1005. No abstract available.

PMID:
21789782
40.

Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells.

Chircop M, Perera S, Mariana A, Lau H, Ma MP, Gilbert J, Jones NC, Gordon CP, Young KA, Morokoff A, Sakoff J, O'Brien TJ, McCluskey A, Robinson PJ.

Mol Cancer Ther. 2011 Sep;10(9):1553-62. doi: 10.1158/1535-7163.MCT-11-0067. Epub 2011 Jul 12.

41.

Spontaneous spinal epidural haematoma in a geriatric patient on aspirin.

Dimou J, Jithoo R, Morokoff A.

J Clin Neurosci. 2010 Jan;17(1):142-4. doi: 10.1016/j.jocn.2009.03.021. Epub 2009 Nov 13.

PMID:
19914071
42.

Spinal cord compression as the initial presentation of acute biphenotypic leukaemia.

Dimou J, Jithoo R, Tsui A, Morokoff AP.

J Clin Neurosci. 2009 Dec;16(12):1696-8. doi: 10.1016/j.jocn.2009.03.047. Epub 2009 Oct 7.

PMID:
19815414
43.

Surgery for convexity meningiomas.

Morokoff AP, Zauberman J, Black PM.

Neurosurgery. 2008 Sep;63(3):427-33; discussion 433-4. doi: 10.1227/01.NEU.0000310692.80289.28.

PMID:
18812953
44.

Surgery for extra-axial tumors of the cerebral convexity and midline.

Black PM, Morokoff AP, Zauberman J.

Neurosurgery. 2008 Jun;62(6 Suppl 3):1115-21; discussion 1121-3. doi: 10.1227/01.neu.0000333778.66316.38. Review.

PMID:
18695533
45.

Meningiomas: science and surgery.

Black P, Morokoff A, Zauberman J, Claus E, Carroll R.

Clin Neurosurg. 2007;54:91-9. No abstract available.

PMID:
18504903
46.

Diffuse choroid plexus hyperplasia: an under-diagnosed cause of hydrocephalus in children?

Aziz AA, Coleman L, Morokoff A, Maixner W.

Pediatr Radiol. 2005 Aug;35(8):815-8. Epub 2005 Apr 27.

PMID:
15856215
47.

Targeted therapy for malignant gliomas.

Morokoff AP, Novak U.

J Clin Neurosci. 2004 Nov;11(8):807-18. Review.

PMID:
15519855
48.

Unusual imaging appearance of an intracranial dermoid cyst.

Brown JY, Morokoff AP, Mitchell PJ, Gonzales MF.

AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1970-2.

49.

Idiopathic spinal cord herniation.

Morokoff AP, Tress BM, Kaye AH.

J Clin Neurosci. 2001 Mar;8(2):180-3. Review.

PMID:
11243773

Supplemental Content

Loading ...
Support Center